This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Anorexiants Market

Market Insights on Anorexiants covering sales outlook, demand forecast & up-to-date key trends

Anorexiants Market By Drug Class, Route of Administration, End User & Region - Forecast 2022 – 2032

Anorexiants Market Outlook (2022-2032)

[250 Pages Report] The global anorexiant market is expected to reach a valuation of approximately US$ 1 Bn in 2022. Sales in the  anorexiants market are likely to increase at a CAGR of 5.3% over the forecast period. Growth can be attributed to the rising prevalence of obesity. As per a May 2022 report published by the CDC, the U.S. recorded an increase from 35% to 41.9%; from the year 1990-2000 through 2017-2020.

In 2021, WHO reported that 39 million children under the age of 5 and over 600 million adults are obese. This factor is fueling expenditure in the healthcare sector, which is expected to underpin demand for anorexiants in the forthcoming years.

Report Attribute

Details

Anorexiants Market Estimated Size (2022)

US$ 1 Bn

Anorexiants Market Projected Growth Rate (2022-2032)

5.3% CAGR

Customize this Report

Let us know your requirement to get
100% FREE customization

How High Prevalence of Obesity is Fueling Sales of Anorexiants?

Anorexiants are therapeutics used in the management of obesity. These drugs work by repressing appetite; inducing satiety, and thereby decreasing the food intake. As the rate of obesity, which is identified as the root cause of most preventable diseases, increases across the globe; sales in the anorexiant market will increase.

Upsurge in geriatric population, rising government initiatives to spread awareness, along with increasing disposable income are some factors contributing to the growth in the market.

Another factor that is central to rising demand for anorexiants is the increase in investments in the healthcare sector. Private and government agencies are investing in the expansion of the healthcare sector in various countries. These investments, along rising research & developmental activities, emergence of new players, and advancing technology create a conducive environment for the expansion of the anorexiants market.

Which Regions are Leading the Anorexiant Market?

The anorexiants market, internationally, is split into seven key regions: North America, Latin America, Western Europe, Eastern Europe, the Asia Pacific excluding Japan, and Middle East & Africa. North America is estimated to be the largest market for anorexiants because of high rates of obesity and its approach towards the adoption of new drugs.

The rise in the development of new drugs, easy sanctions of drugs, and advancement in healthcare facilities and technologies have contributed to the growth of the anorexiants market in Europe.

Asia Pacific is expected to emerge as a lucrative pocket in the global anorexiants market owing to rising demand for new and improved treatment options. Further, growing cases of weight gain and consequent obesity act as a stimulant for demand in the anorexiants market.

Compared to the scope of growth in regions such as North America, Europe, Asia Pacific, the Middle East, and Africa are less contributing areas. Poor healthcare facilities, fewer instances of new drug adoption, and a lack of awareness among the population are some factors that hinder the growth in the anorexiant market in these regions.

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

Which Factors are Obstructing the Growth in the Anorexiants Market?

Certain challenges that the anorexiants market faces is high cost of development and distribution of drugs. Poor healthcare facilities, lack of skilled professionals as well as low awareness among people might limit sales of anorexiants. Further, resultant side-effects from the consumption of the drug also impede the growth in the market.

What are the Key Trends Influencing Sales of Anorexiants?

Demand for oral anorexiants is estimated to remain high over the forecast period due to patients’ preference for non-invasive treatments, and the ease of administration of oral anorexiants. Additionally, the easy availability of the product in the form of tablets and capsules, as well as well-informed key players are also expected to boost sales in the forthcoming years.

Another notable trend is the continued dominance of North America in the market due to rising prevalence of obesity and related diseases, easy adoption of new drugs, the presence of key players, and high awareness among consumers. These factors will place North America as the leading anorexiants market over the assessment period.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Market Competition

Leading players operating in the global anorexiants market are investing in research and development to improve their product portfolios. They are also aiming at production facility expansions through mergers, acquisitions and collaborations.

For instance, in 2019, Currax Pharmaceuticals LLC, gained the global rights to Contrave, the leading prescription for weight loss in the United States and Europe after acquiring Nalpropion Pharmaceuticals, a biopharmaceutical company focused on weight loss treatment.

Some of the key players operating in the market include Akrimax Pharmaceuticals, LLC, Teva Pharmaceuticals, Janssen Ortho, LLC, Roche Pharmaceuticals, Arena Pharmaceuticals GmbH, Novo Nordisk A/S, Abbott Pharmaceuticals PR Ltd, Epic Pharma, LLC., Patheon Pharmaceuticals Inc., Catalent Pharma Solutions, LLC, Recordati Rare Diseases Inc., and MOVA Pharmaceuticals.

Report Scope

Report Attribute

Details

Growth Rate

CAGR of 5.3% from 2022 to 2032

Base Year for Estimation

2021

Historical Data

2015-2021

Forecast Period

2022-2032

Quantitative Units

Revenue in US$ Million, Volume in Kilotons and CAGR from 2022-2032

Report Coverage

Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis

Segments Covered

  • Drug Class
  • Route of Administration
  • End User
  • Region

Countries Covered

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East and Africa

Key Companies Profiled

Customization

Available Upon Request

Key Segments Profiled in the Anorexiants Market Survey

By Drug Class:

  • Catecholamines Anorexiants
  • Serotonin Anorexiants

By Route of Administration:

  • Oral
  • Subcutaneous

By End User:

  • Institutional sales
  • Hospitals
  • Clinics
  • Retail sales
  • Online pharmacies
  • Mail Order Pharmacies

By Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East and Africa

Frequently Asked Questions

The global anorexiants market is projected to expand at a 5.3% CAGR over the assessment period.

High incidence of obesity, along with increasing investments in the healthcare sector by private and government agencies across emerging economies will augment sales of anorexiants in the forthcoming years.

Akrimax Pharmaceuticals, LLC, Teva Pharmaceuticals, Janssen Ortho, LLC, Roche Pharmaceuticals, and Arena Pharmaceuticals GmbH are some of the key manufacturers of anorexiants.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity 

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Product Life Cycle Analysis

    3.5. Supply Chain Analysis

        3.5.1. Supply Side Participants and their Roles

            3.5.1.1. Producers

            3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers)

            3.5.1.3. Wholesalers and Distributors

        3.5.2. Value Added and Value Created at Node in the Supply Chain

        3.5.3. List of Raw Material Suppliers

        3.5.4. List of Existing and Potential Buyer’s

    3.6. Investment Feasibility Matrix

    3.7. Value Chain Analysis

        3.7.1. Profit Margin Analysis

        3.7.2. Wholesalers and Distributors

        3.7.3. Retailers

    3.8. PESTLE and Porter’s Analysis

    3.9. Regulatory Landscape

        3.9.1. By Key Regions

        3.9.2. By Key Countries

    3.10. Regional Parent Market Outlook

    3.11. Production and Consumption Statistics

    3.12. Import and Export Statistics

4. Global Anorexiants Market Analysis 2017-2021 and Forecast, 2022-2032

    4.1. Historical Market Size Value (US$ Mn) & Volume (Tons) Analysis, 2017-2021

    4.2. Current and Future Market Size Value (US$ Mn) & Volume (Tons) Projections, 2022-2032

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Anorexiants Market Analysis 2017-2021 and Forecast 2022-2032, By Drug Class

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Mn) & Volume (Tons) Analysis By Drug Class, 2017-2021

    5.3. Current and Future Market Size Value (US$ Mn) & Volume (Tons) Analysis and Forecast By Drug Class, 2022-2032

        5.3.1. Catecholamines Anorexiants

        5.3.2. Serotonin Anorexiants

    5.4. Y-o-Y Growth Trend Analysis By Drug Class, 2017-2021

    5.5. Absolute $ Opportunity Analysis By Drug Class, 2022-2032

6. Global Anorexiants Market Analysis 2017-2021 and Forecast 2022-2032, By Route of Administration

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ Mn) & Volume (Tons) Analysis By Route of Administration, 2017-2021

    6.3. Current and Future Market Size Value (US$ Mn) & Volume (Tons) Analysis and Forecast By Route of Administration, 2022-2032

        6.3.1. Oral

        6.3.2. Subcutaneous

    6.4. Y-o-Y Growth Trend Analysis By Route of Administration, 2017-2021

    6.5. Absolute $ Opportunity Analysis By Route of Administration, 2022-2032

7. Global Anorexiants Market Analysis 2017-2021 and Forecast 2022-2032, By End User

    7.1. Introduction / Key Findings

    7.2. Historical Market Size Value (US$ Mn) & Volume (Tons) Analysis By End User, 2017-2021

    7.3. Current and Future Market Size Value (US$ Mn) & Volume (Tons) Analysis and Forecast By End User, 2022-2032

        7.3.1. Institutional Sales

        7.3.2. Hospitals

        7.3.3. Clinics

        7.3.4. Retail Sales

        7.3.5. Online Pharmacies

        7.3.6. Mail Order Pharmacies

    7.4. Y-o-Y Growth Trend Analysis By End User, 2017-2021

    7.5. Absolute $ Opportunity Analysis By End User, 2022-2032

8. Global Anorexiants Market Analysis 2017-2021 and Forecast 2022-2032, By Region

    8.1. Introduction

    8.2. Historical Market Size Value (US$ Mn) & Volume (Tons) Analysis By Region, 2017-2021

    8.3. Current Market Size Value (US$ Mn) & Volume (Tons) Analysis and Forecast By Region, 2022-2032

        8.3.1. North America

        8.3.2. Latin America

        8.3.3. Europe

        8.3.4. East Asia

        8.3.5. South Asia & Pacific

        8.3.6. MEA

    8.4. Market Attractiveness Analysis By Region

9. North America Anorexiants Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    9.1. Historical Market Size Value (US$ Mn) & Volume (Tons) Trend Analysis By Market Taxonomy, 2017-2021

    9.2. Market Size Value (US$ Mn) & Volume (Tons) Forecast By Market Taxonomy, 2022-2032

        9.2.1. By Country

            9.2.1.1. U.S.

            9.2.1.2. Canada

        9.2.2. By Drug Class

        9.2.3. By Route of Administration

        9.2.4. By End User

    9.3. Market Attractiveness Analysis

        9.3.1. By Country

        9.3.2. By Drug Class

        9.3.3. By Route of Administration

        9.3.4. By End User

    9.4. Key Takeaways

10. Latin America Anorexiants Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    10.1. Historical Market Size Value (US$ Mn) & Volume (Tons) Trend Analysis By Market Taxonomy, 2017-2021

    10.2. Market Size Value (US$ Mn) & Volume (Tons) Forecast By Market Taxonomy, 2022-2032

        10.2.1. By Country

            10.2.1.1. Mexico

            10.2.1.2. Brazil

            10.2.1.3. Rest of Latin America

        10.2.2. By Drug Class

        10.2.3. By Route of Administration

        10.2.4. By End User

    10.3. Market Attractiveness Analysis

        10.3.1. By Country

        10.3.2. By Drug Class

        10.3.3. By Route of Administration

        10.3.4. By End User

    10.4. Key Takeaways

11. Europe Anorexiants Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    11.1. Historical Market Size Value (US$ Mn) & Volume (Tons) Trend Analysis By Market Taxonomy, 2017-2021

    11.2. Market Size Value (US$ Mn) & Volume (Tons) Forecast By Market Taxonomy, 2022-2032

        11.2.1. By Country

            11.2.1.1. Germany

            11.2.1.2. Italy

            11.2.1.3. France

            11.2.1.4. U.K.

            11.2.1.5. Spain

            11.2.1.6. BENELUX

            11.2.1.7. Russia

            11.2.1.8. Rest of Europe

        11.2.2. By Drug Class

        11.2.3. By Route of Administration

        11.2.4. By End User

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Drug Class

        11.3.3. By Route of Administration

        11.3.4. By End User

    11.4. Key Takeaways

12. East Asia Anorexiants Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    12.1. Historical Market Size Value (US$ Mn) & Volume (Tons) Trend Analysis By Market Taxonomy, 2017-2021

    12.2. Market Size Value (US$ Mn) & Volume (Tons) Forecast By Market Taxonomy, 2022-2032

        12.2.1. By Country

            12.2.1.1. China

            12.2.1.2. Japan

            12.2.1.3. South Korea

        12.2.2. By Drug Class

        12.2.3. By Route of Administration

        12.2.4. By End User

    12.3. Market Attractiveness Analysis

        12.3.1. By Country

        12.3.2. By Drug Class

        12.3.3. By Route of Administration

        12.3.4. By End User

    12.4. Key Takeaways

13. South Asia & Pacific Anorexiants Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    13.1. Historical Market Size Value (US$ Mn) & Volume (Tons) Trend Analysis By Market Taxonomy, 2017-2021

    13.2. Market Size Value (US$ Mn) & Volume (Tons) Forecast By Market Taxonomy, 2022-2032

        13.2.1. By Country

            13.2.1.1. India

            13.2.1.2. ASEAN

            13.2.1.3. Australia and New Zealand

            13.2.1.4. Rest of South Asia & Pacific

        13.2.2. By Drug Class

        13.2.3. By Route of Administration

        13.2.4. By End User

    13.3. Market Attractiveness Analysis

        13.3.1. By Country

        13.3.2. By Drug Class

        13.3.3. By Route of Administration

        13.3.4. By End User

    13.4. Key Takeaways

14. MEA Anorexiants Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    14.1. Historical Market Size Value (US$ Mn) & Volume (Tons) Trend Analysis By Market Taxonomy, 2017-2021

    14.2. Market Size Value (US$ Mn) & Volume (Tons) Forecast By Market Taxonomy, 2022-2032

        14.2.1. By Country

            14.2.1.1. GCC Countries

            14.2.1.2. Turkey

            14.2.1.3. South Africa

            14.2.1.4. Rest of MEA

        14.2.2. By Drug Class

        14.2.3. By Route of Administration

        14.2.4. By End User

    14.3. Market Attractiveness Analysis

        14.3.1. By Country

        14.3.2. By Drug Class

        14.3.3. By Route of Administration

        14.3.4. By End User

    14.4. Key Takeaways

15. Key Countries Anorexiants Market Analysis

    15.1. U.S.

        15.1.1. Pricing Analysis

        15.1.2. Market Share Analysis, 2021

            15.1.2.1. By Drug Class

            15.1.2.2. By Route of Administration

            15.1.2.3. By End User

    15.2. Canada

        15.2.1. Pricing Analysis

        15.2.2. Market Share Analysis, 2021

            15.2.2.1. By Drug Class

            15.2.2.2. By Route of Administration

            15.2.2.3. By End User

    15.3. Mexico

        15.3.1. Pricing Analysis

        15.3.2. Market Share Analysis, 2021

            15.3.2.1. By Drug Class

            15.3.2.2. By Route of Administration

            15.3.2.3. By End User

    15.4. Brazil

        15.4.1. Pricing Analysis

        15.4.2. Market Share Analysis, 2021

            15.4.2.1. By Drug Class

            15.4.2.2. By Route of Administration

            15.4.2.3. By End User

    15.5. Germany

        15.5.1. Pricing Analysis

        15.5.2. Market Share Analysis, 2021

            15.5.2.1. By Drug Class

            15.5.2.2. By Route of Administration

            15.5.2.3. By End User

    15.6. Italy

        15.6.1. Pricing Analysis

        15.6.2. Market Share Analysis, 2021

            15.6.2.1. By Drug Class

            15.6.2.2. By Route of Administration

            15.6.2.3. By End User

    15.7. France

        15.7.1. Pricing Analysis

        15.7.2. Market Share Analysis, 2021

            15.7.2.1. By Drug Class

            15.7.2.2. By Route of Administration

            15.7.2.3. By End User

    15.8. U.K.

        15.8.1. Pricing Analysis

        15.8.2. Market Share Analysis, 2021

            15.8.2.1. By Drug Class

            15.8.2.2. By Route of Administration

            15.8.2.3. By End User

    15.9. Spain

        15.9.1. Pricing Analysis

        15.9.2. Market Share Analysis, 2021

            15.9.2.1. By Drug Class

            15.9.2.2. By Route of Administration

            15.9.2.3. By End User

    15.10. BENELUX

        15.10.1. Pricing Analysis

        15.10.2. Market Share Analysis, 2021

            15.10.2.1. By Drug Class

            15.10.2.2. By Route of Administration

            15.10.2.3. By End User

    15.11. Russia

        15.11.1. Pricing Analysis

        15.11.2. Market Share Analysis, 2021

            15.11.2.1. By Drug Class

            15.11.2.2. By Route of Administration

            15.11.2.3. By End User

    15.12. China

        15.12.1. Pricing Analysis

        15.12.2. Market Share Analysis, 2021

            15.12.2.1. By Drug Class

            15.12.2.2. By Route of Administration

            15.12.2.3. By End User

    15.13. Japan

        15.13.1. Pricing Analysis

        15.13.2. Market Share Analysis, 2021

            15.13.2.1. By Drug Class

            15.13.2.2. By Route of Administration

            15.13.2.3. By End User

    15.14. South Korea

        15.14.1. Pricing Analysis

        15.14.2. Market Share Analysis, 2021

            15.14.2.1. By Drug Class

            15.14.2.2. By Route of Administration

            15.14.2.3. By End User

    15.15. India

        15.15.1. Pricing Analysis

        15.15.2. Market Share Analysis, 2021

            15.15.2.1. By Drug Class

            15.15.2.2. By Route of Administration

            15.15.2.3. By End User

    15.16. ASEAN

        15.16.1. Pricing Analysis

        15.16.2. Market Share Analysis, 2021

            15.16.2.1. By Drug Class

            15.16.2.2. By Route of Administration

            15.16.2.3. By End User

    15.17. Australia and New Zealand

        15.17.1. Pricing Analysis

        15.17.2. Market Share Analysis, 2021

            15.17.2.1. By Drug Class

            15.17.2.2. By Route of Administration

            15.17.2.3. By End User

    15.18. GCC Countries

        15.18.1. Pricing Analysis

        15.18.2. Market Share Analysis, 2021

            15.18.2.1. By Drug Class

            15.18.2.2. By Route of Administration

            15.18.2.3. By End User

    15.19. Turkey

        15.19.1. Pricing Analysis

        15.19.2. Market Share Analysis, 2021

            15.19.2.1. By Drug Class

            15.19.2.2. By Route of Administration

            15.19.2.3. By End User

    15.20. South Africa

        15.20.1. Pricing Analysis

        15.20.2. Market Share Analysis, 2021

            15.20.2.1. By Drug Class

            15.20.2.2. By Route of Administration

            15.20.2.3. By End User

16. Market Structure Analysis

    16.1. Competition Dashboard

    16.2. Competition Benchmarking

    16.3. Market Share Analysis of Top Players

        16.3.1. By Regional

        16.3.2. By Drug Class

        16.3.3. By Route of Administration

        16.3.4. By End User

17. Competition Analysis

    17.1. Competition Deep Dive

        17.1.1. Teva Pharmaceuticals

            17.1.1.1. Overview

            17.1.1.2. Product Portfolio

            17.1.1.3. Profitability by Market Segments

            17.1.1.4. Sales Footprint

            17.1.1.5. Strategy Overview

                17.1.1.5.1. Marketing Strategy

                17.1.1.5.2. Product Strategy

                17.1.1.5.3. Channel Strategy

        17.1.2. Janssen Ortho, LLC

            17.1.2.1. Overview

            17.1.2.2. Product Portfolio

            17.1.2.3. Profitability by Market Segments

            17.1.2.4. Sales Footprint

            17.1.2.5. Strategy Overview

                17.1.2.5.1. Marketing Strategy

                17.1.2.5.2. Product Strategy

                17.1.2.5.3. Channel Strategy

        17.1.3. Roche Pharmaceuticals

            17.1.3.1. Overview

            17.1.3.2. Product Portfolio

            17.1.3.3. Profitability by Market Segments

            17.1.3.4. Sales Footprint

            17.1.3.5. Strategy Overview

                17.1.3.5.1. Marketing Strategy

                17.1.3.5.2. Product Strategy

                17.1.3.5.3. Channel Strategy

        17.1.4. Pfizer

            17.1.4.1. Overview

            17.1.4.2. Product Portfolio

            17.1.4.3. Profitability by Market Segments

            17.1.4.4. Sales Footprint

            17.1.4.5. Strategy Overview

                17.1.4.5.1. Marketing Strategy

                17.1.4.5.2. Product Strategy

                17.1.4.5.3. Channel Strategy

        17.1.5. Novo Nordisk A/S

            17.1.5.1. Overview

            17.1.5.2. Product Portfolio

            17.1.5.3. Profitability by Market Segments

            17.1.5.4. Sales Footprint

            17.1.5.5. Strategy Overview

                17.1.5.5.1. Marketing Strategy

                17.1.5.5.2. Product Strategy

                17.1.5.5.3. Channel Strategy

        17.1.6. Abbott Pharmaceuticals PR Ltd.

            17.1.6.1. Overview

            17.1.6.2. Product Portfolio

            17.1.6.3. Profitability by Market Segments

            17.1.6.4. Sales Footprint

            17.1.6.5. Strategy Overview

                17.1.6.5.1. Marketing Strategy

                17.1.6.5.2. Product Strategy

                17.1.6.5.3. Channel Strategy

        17.1.7. Epic Pharma, LLC.

            17.1.7.1. Overview

            17.1.7.2. Product Portfolio

            17.1.7.3. Profitability by Market Segments

            17.1.7.4. Sales Footprint

            17.1.7.5. Strategy Overview

                17.1.7.5.1. Marketing Strategy

                17.1.7.5.2. Product Strategy

                17.1.7.5.3. Channel Strategy

        17.1.8. Patheon Pharmaceuticals Inc.

            17.1.8.1. Overview

            17.1.8.2. Product Portfolio

            17.1.8.3. Profitability by Market Segments

            17.1.8.4. Sales Footprint

            17.1.8.5. Strategy Overview

                17.1.8.5.1. Marketing Strategy

                17.1.8.5.2. Product Strategy

                17.1.8.5.3. Channel Strategy

        17.1.9. Catalent Pharma Solutions, LLC

            17.1.9.1. Overview

            17.1.9.2. Product Portfolio

            17.1.9.3. Profitability by Market Segments

            17.1.9.4. Sales Footprint

            17.1.9.5. Strategy Overview

                17.1.9.5.1. Marketing Strategy

                17.1.9.5.2. Product Strategy

                17.1.9.5.3. Channel Strategy

        17.1.10. Recordati Rare Diseases Inc.

            17.1.10.1. Overview

            17.1.10.2. Product Portfolio

            17.1.10.3. Profitability by Market Segments

            17.1.10.4. Sales Footprint

            17.1.10.5. Strategy Overview

                17.1.10.5.1. Marketing Strategy

                17.1.10.5.2. Product Strategy

                17.1.10.5.3. Channel Strategy

        17.1.11. MOVA Pharmaceuticals

            17.1.11.1. Overview

            17.1.11.2. Product Portfolio

            17.1.11.3. Profitability by Market Segments

            17.1.11.4. Sales Footprint

            17.1.11.5. Strategy Overview

                17.1.11.5.1. Marketing Strategy

                17.1.11.5.2. Product Strategy

                17.1.11.5.3. Channel Strategy

18. Assumptions & Acronyms Used

19. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 1: Global Anorexiants Market Value (US$ Mn) Forecast by Region, 2017-2032

Table 2: Global Anorexiants Market Volume (Tons) Forecast by Region, 2017-2032

Table 3: Global Anorexiants Market Value (US$ Mn) Forecast by Drug Class, 2017-2032

Table 4: Global Anorexiants Market Volume (Tons) Forecast by Drug Class, 2017-2032

Table 5: Global Anorexiants Market Value (US$ Mn) Forecast by Route of Administration, 2017-2032

Table 6: Global Anorexiants Market Volume (Tons) Forecast by Route of Administration, 2017-2032

Table 7: Global Anorexiants Market Value (US$ Mn) Forecast by End User, 2017-2032

Table 8: Global Anorexiants Market Volume (Tons) Forecast by End User, 2017-2032

Table 9: North America Anorexiants Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 10: North America Anorexiants Market Volume (Tons) Forecast by Country, 2017-2032

Table 11: North America Anorexiants Market Value (US$ Mn) Forecast by Drug Class, 2017-2032

Table 12: North America Anorexiants Market Volume (Tons) Forecast by Drug Class, 2017-2032

Table 13: North America Anorexiants Market Value (US$ Mn) Forecast by Route of Administration, 2017-2032

Table 14: North America Anorexiants Market Volume (Tons) Forecast by Route of Administration, 2017-2032

Table 15: North America Anorexiants Market Value (US$ Mn) Forecast by End User, 2017-2032

Table 16: North America Anorexiants Market Volume (Tons) Forecast by End User, 2017-2032

Table 17: Latin America Anorexiants Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 18: Latin America Anorexiants Market Volume (Tons) Forecast by Country, 2017-2032

Table 19: Latin America Anorexiants Market Value (US$ Mn) Forecast by Drug Class, 2017-2032

Table 20: Latin America Anorexiants Market Volume (Tons) Forecast by Drug Class, 2017-2032

Table 21: Latin America Anorexiants Market Value (US$ Mn) Forecast by Route of Administration, 2017-2032

Table 22: Latin America Anorexiants Market Volume (Tons) Forecast by Route of Administration, 2017-2032

Table 23: Latin America Anorexiants Market Value (US$ Mn) Forecast by End User, 2017-2032

Table 24: Latin America Anorexiants Market Volume (Tons) Forecast by End User, 2017-2032

Table 25: Europe Anorexiants Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 26: Europe Anorexiants Market Volume (Tons) Forecast by Country, 2017-2032

Table 27: Europe Anorexiants Market Value (US$ Mn) Forecast by Drug Class, 2017-2032

Table 28: Europe Anorexiants Market Volume (Tons) Forecast by Drug Class, 2017-2032

Table 29: Europe Anorexiants Market Value (US$ Mn) Forecast by Route of Administration, 2017-2032

Table 30: Europe Anorexiants Market Volume (Tons) Forecast by Route of Administration, 2017-2032

Table 31: Europe Anorexiants Market Value (US$ Mn) Forecast by End User, 2017-2032

Table 32: Europe Anorexiants Market Volume (Tons) Forecast by End User, 2017-2032

Table 33: East Asia Anorexiants Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 34: East Asia Anorexiants Market Volume (Tons) Forecast by Country, 2017-2032

Table 35: East Asia Anorexiants Market Value (US$ Mn) Forecast by Drug Class, 2017-2032

Table 36: East Asia Anorexiants Market Volume (Tons) Forecast by Drug Class, 2017-2032

Table 37: East Asia Anorexiants Market Value (US$ Mn) Forecast by Route of Administration, 2017-2032

Table 38: East Asia Anorexiants Market Volume (Tons) Forecast by Route of Administration, 2017-2032

Table 39: East Asia Anorexiants Market Value (US$ Mn) Forecast by End User, 2017-2032

Table 40: East Asia Anorexiants Market Volume (Tons) Forecast by End User, 2017-2032

Table 41: South Asia & Pacific Anorexiants Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 42: South Asia & Pacific Anorexiants Market Volume (Tons) Forecast by Country, 2017-2032

Table 43: South Asia & Pacific Anorexiants Market Value (US$ Mn) Forecast by Drug Class, 2017-2032

Table 44: South Asia & Pacific Anorexiants Market Volume (Tons) Forecast by Drug Class, 2017-2032

Table 45: South Asia & Pacific Anorexiants Market Value (US$ Mn) Forecast by Route of Administration, 2017-2032

Table 46: South Asia & Pacific Anorexiants Market Volume (Tons) Forecast by Route of Administration, 2017-2032

Table 47: South Asia & Pacific Anorexiants Market Value (US$ Mn) Forecast by End User, 2017-2032

Table 48: South Asia & Pacific Anorexiants Market Volume (Tons) Forecast by End User, 2017-2032

Table 49: MEA Anorexiants Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 50: MEA Anorexiants Market Volume (Tons) Forecast by Country, 2017-2032

Table 51: MEA Anorexiants Market Value (US$ Mn) Forecast by Drug Class, 2017-2032

Table 52: MEA Anorexiants Market Volume (Tons) Forecast by Drug Class, 2017-2032

Table 53: MEA Anorexiants Market Value (US$ Mn) Forecast by Route of Administration, 2017-2032

Table 54: MEA Anorexiants Market Volume (Tons) Forecast by Route of Administration, 2017-2032

Table 55: MEA Anorexiants Market Value (US$ Mn) Forecast by End User, 2017-2032

Table 56: MEA Anorexiants Market Volume (Tons) Forecast by End User, 2017-2032

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

Figure 1: Global Anorexiants Market Value (US$ Mn) by Drug Class, 2022-2032

Figure 2: Global Anorexiants Market Value (US$ Mn) by Route of Administration, 2022-2032

Figure 3: Global Anorexiants Market Value (US$ Mn) by End User, 2022-2032

Figure 4: Global Anorexiants Market Value (US$ Mn) by Region, 2022-2032

Figure 5: Global Anorexiants Market Value (US$ Mn) Analysis by Region, 2017-2032

Figure 6: Global Anorexiants Market Volume (Tons) Analysis by Region, 2017-2032

Figure 7: Global Anorexiants Market Value Share (%) and BPS Analysis by Region, 2022-2032

Figure 8: Global Anorexiants Market Y-o-Y Growth (%) Projections by Region, 2022-2032

Figure 9: Global Anorexiants Market Value (US$ Mn) Analysis by Drug Class, 2017-2032

Figure 10: Global Anorexiants Market Volume (Tons) Analysis by Drug Class, 2017-2032

Figure 11: Global Anorexiants Market Value Share (%) and BPS Analysis by Drug Class, 2022-2032

Figure 12: Global Anorexiants Market Y-o-Y Growth (%) Projections by Drug Class, 2022-2032

Figure 13: Global Anorexiants Market Value (US$ Mn) Analysis by Route of Administration, 2017-2032

Figure 14: Global Anorexiants Market Volume (Tons) Analysis by Route of Administration, 2017-2032

Figure 15: Global Anorexiants Market Value Share (%) and BPS Analysis by Route of Administration, 2022-2032

Figure 16: Global Anorexiants Market Y-o-Y Growth (%) Projections by Route of Administration, 2022-2032

Figure 17: Global Anorexiants Market Value (US$ Mn) Analysis by End User, 2017-2032

Figure 18: Global Anorexiants Market Volume (Tons) Analysis by End User, 2017-2032

Figure 19: Global Anorexiants Market Value Share (%) and BPS Analysis by End User, 2022-2032

Figure 20: Global Anorexiants Market Y-o-Y Growth (%) Projections by End User, 2022-2032

Figure 21: Global Anorexiants Market Attractiveness by Drug Class, 2022-2032

Figure 22: Global Anorexiants Market Attractiveness by Route of Administration, 2022-2032

Figure 23: Global Anorexiants Market Attractiveness by End User, 2022-2032

Figure 24: Global Anorexiants Market Attractiveness by Region, 2022-2032

Figure 25: North America Anorexiants Market Value (US$ Mn) by Drug Class, 2022-2032

Figure 26: North America Anorexiants Market Value (US$ Mn) by Route of Administration, 2022-2032

Figure 27: North America Anorexiants Market Value (US$ Mn) by End User, 2022-2032

Figure 28: North America Anorexiants Market Value (US$ Mn) by Country, 2022-2032

Figure 29: North America Anorexiants Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 30: North America Anorexiants Market Volume (Tons) Analysis by Country, 2017-2032

Figure 31: North America Anorexiants Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 32: North America Anorexiants Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 33: North America Anorexiants Market Value (US$ Mn) Analysis by Drug Class, 2017-2032

Figure 34: North America Anorexiants Market Volume (Tons) Analysis by Drug Class, 2017-2032

Figure 35: North America Anorexiants Market Value Share (%) and BPS Analysis by Drug Class, 2022-2032

Figure 36: North America Anorexiants Market Y-o-Y Growth (%) Projections by Drug Class, 2022-2032

Figure 37: North America Anorexiants Market Value (US$ Mn) Analysis by Route of Administration, 2017-2032

Figure 38: North America Anorexiants Market Volume (Tons) Analysis by Route of Administration, 2017-2032

Figure 39: North America Anorexiants Market Value Share (%) and BPS Analysis by Route of Administration, 2022-2032

Figure 40: North America Anorexiants Market Y-o-Y Growth (%) Projections by Route of Administration, 2022-2032

Figure 41: North America Anorexiants Market Value (US$ Mn) Analysis by End User, 2017-2032

Figure 42: North America Anorexiants Market Volume (Tons) Analysis by End User, 2017-2032

Figure 43: North America Anorexiants Market Value Share (%) and BPS Analysis by End User, 2022-2032

Figure 44: North America Anorexiants Market Y-o-Y Growth (%) Projections by End User, 2022-2032

Figure 45: North America Anorexiants Market Attractiveness by Drug Class, 2022-2032

Figure 46: North America Anorexiants Market Attractiveness by Route of Administration, 2022-2032

Figure 47: North America Anorexiants Market Attractiveness by End User, 2022-2032

Figure 48: North America Anorexiants Market Attractiveness by Country, 2022-2032

Figure 49: Latin America Anorexiants Market Value (US$ Mn) by Drug Class, 2022-2032

Figure 50: Latin America Anorexiants Market Value (US$ Mn) by Route of Administration, 2022-2032

Figure 51: Latin America Anorexiants Market Value (US$ Mn) by End User, 2022-2032

Figure 52: Latin America Anorexiants Market Value (US$ Mn) by Country, 2022-2032

Figure 53: Latin America Anorexiants Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 54: Latin America Anorexiants Market Volume (Tons) Analysis by Country, 2017-2032

Figure 55: Latin America Anorexiants Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 56: Latin America Anorexiants Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 57: Latin America Anorexiants Market Value (US$ Mn) Analysis by Drug Class, 2017-2032

Figure 58: Latin America Anorexiants Market Volume (Tons) Analysis by Drug Class, 2017-2032

Figure 59: Latin America Anorexiants Market Value Share (%) and BPS Analysis by Drug Class, 2022-2032

Figure 60: Latin America Anorexiants Market Y-o-Y Growth (%) Projections by Drug Class, 2022-2032

Figure 61: Latin America Anorexiants Market Value (US$ Mn) Analysis by Route of Administration, 2017-2032

Figure 62: Latin America Anorexiants Market Volume (Tons) Analysis by Route of Administration, 2017-2032

Figure 63: Latin America Anorexiants Market Value Share (%) and BPS Analysis by Route of Administration, 2022-2032

Figure 64: Latin America Anorexiants Market Y-o-Y Growth (%) Projections by Route of Administration, 2022-2032

Figure 65: Latin America Anorexiants Market Value (US$ Mn) Analysis by End User, 2017-2032

Figure 66: Latin America Anorexiants Market Volume (Tons) Analysis by End User, 2017-2032

Figure 67: Latin America Anorexiants Market Value Share (%) and BPS Analysis by End User, 2022-2032

Figure 68: Latin America Anorexiants Market Y-o-Y Growth (%) Projections by End User, 2022-2032

Figure 69: Latin America Anorexiants Market Attractiveness by Drug Class, 2022-2032

Figure 70: Latin America Anorexiants Market Attractiveness by Route of Administration, 2022-2032

Figure 71: Latin America Anorexiants Market Attractiveness by End User, 2022-2032

Figure 72: Latin America Anorexiants Market Attractiveness by Country, 2022-2032

Figure 73: Europe Anorexiants Market Value (US$ Mn) by Drug Class, 2022-2032

Figure 74: Europe Anorexiants Market Value (US$ Mn) by Route of Administration, 2022-2032

Figure 75: Europe Anorexiants Market Value (US$ Mn) by End User, 2022-2032

Figure 76: Europe Anorexiants Market Value (US$ Mn) by Country, 2022-2032

Figure 77: Europe Anorexiants Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 78: Europe Anorexiants Market Volume (Tons) Analysis by Country, 2017-2032

Figure 79: Europe Anorexiants Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 80: Europe Anorexiants Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 81: Europe Anorexiants Market Value (US$ Mn) Analysis by Drug Class, 2017-2032

Figure 82: Europe Anorexiants Market Volume (Tons) Analysis by Drug Class, 2017-2032

Figure 83: Europe Anorexiants Market Value Share (%) and BPS Analysis by Drug Class, 2022-2032

Figure 84: Europe Anorexiants Market Y-o-Y Growth (%) Projections by Drug Class, 2022-2032

Figure 85: Europe Anorexiants Market Value (US$ Mn) Analysis by Route of Administration, 2017-2032

Figure 86: Europe Anorexiants Market Volume (Tons) Analysis by Route of Administration, 2017-2032

Figure 87: Europe Anorexiants Market Value Share (%) and BPS Analysis by Route of Administration, 2022-2032

Figure 88: Europe Anorexiants Market Y-o-Y Growth (%) Projections by Route of Administration, 2022-2032

Figure 89: Europe Anorexiants Market Value (US$ Mn) Analysis by End User, 2017-2032

Figure 90: Europe Anorexiants Market Volume (Tons) Analysis by End User, 2017-2032

Figure 91: Europe Anorexiants Market Value Share (%) and BPS Analysis by End User, 2022-2032

Figure 92: Europe Anorexiants Market Y-o-Y Growth (%) Projections by End User, 2022-2032

Figure 93: Europe Anorexiants Market Attractiveness by Drug Class, 2022-2032

Figure 94: Europe Anorexiants Market Attractiveness by Route of Administration, 2022-2032

Figure 95: Europe Anorexiants Market Attractiveness by End User, 2022-2032

Figure 96: Europe Anorexiants Market Attractiveness by Country, 2022-2032

Figure 97: East Asia Anorexiants Market Value (US$ Mn) by Drug Class, 2022-2032

Figure 98: East Asia Anorexiants Market Value (US$ Mn) by Route of Administration, 2022-2032

Figure 99: East Asia Anorexiants Market Value (US$ Mn) by End User, 2022-2032

Figure 100: East Asia Anorexiants Market Value (US$ Mn) by Country, 2022-2032

Figure 101: East Asia Anorexiants Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 102: East Asia Anorexiants Market Volume (Tons) Analysis by Country, 2017-2032

Figure 103: East Asia Anorexiants Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 104: East Asia Anorexiants Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 105: East Asia Anorexiants Market Value (US$ Mn) Analysis by Drug Class, 2017-2032

Figure 106: East Asia Anorexiants Market Volume (Tons) Analysis by Drug Class, 2017-2032

Figure 107: East Asia Anorexiants Market Value Share (%) and BPS Analysis by Drug Class, 2022-2032

Figure 108: East Asia Anorexiants Market Y-o-Y Growth (%) Projections by Drug Class, 2022-2032

Figure 109: East Asia Anorexiants Market Value (US$ Mn) Analysis by Route of Administration, 2017-2032

Figure 110: East Asia Anorexiants Market Volume (Tons) Analysis by Route of Administration, 2017-2032

Figure 111: East Asia Anorexiants Market Value Share (%) and BPS Analysis by Route of Administration, 2022-2032

Figure 112: East Asia Anorexiants Market Y-o-Y Growth (%) Projections by Route of Administration, 2022-2032

Figure 113: East Asia Anorexiants Market Value (US$ Mn) Analysis by End User, 2017-2032

Figure 114: East Asia Anorexiants Market Volume (Tons) Analysis by End User, 2017-2032

Figure 115: East Asia Anorexiants Market Value Share (%) and BPS Analysis by End User, 2022-2032

Figure 116: East Asia Anorexiants Market Y-o-Y Growth (%) Projections by End User, 2022-2032

Figure 117: East Asia Anorexiants Market Attractiveness by Drug Class, 2022-2032

Figure 118: East Asia Anorexiants Market Attractiveness by Route of Administration, 2022-2032

Figure 119: East Asia Anorexiants Market Attractiveness by End User, 2022-2032

Figure 120: East Asia Anorexiants Market Attractiveness by Country, 2022-2032

Figure 121: South Asia & Pacific Anorexiants Market Value (US$ Mn) by Drug Class, 2022-2032

Figure 122: South Asia & Pacific Anorexiants Market Value (US$ Mn) by Route of Administration, 2022-2032

Figure 123: South Asia & Pacific Anorexiants Market Value (US$ Mn) by End User, 2022-2032

Figure 124: South Asia & Pacific Anorexiants Market Value (US$ Mn) by Country, 2022-2032

Figure 125: South Asia & Pacific Anorexiants Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 126: South Asia & Pacific Anorexiants Market Volume (Tons) Analysis by Country, 2017-2032

Figure 127: South Asia & Pacific Anorexiants Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 128: South Asia & Pacific Anorexiants Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 129: South Asia & Pacific Anorexiants Market Value (US$ Mn) Analysis by Drug Class, 2017-2032

Figure 130: South Asia & Pacific Anorexiants Market Volume (Tons) Analysis by Drug Class, 2017-2032

Figure 131: South Asia & Pacific Anorexiants Market Value Share (%) and BPS Analysis by Drug Class, 2022-2032

Figure 132: South Asia & Pacific Anorexiants Market Y-o-Y Growth (%) Projections by Drug Class, 2022-2032

Figure 133: South Asia & Pacific Anorexiants Market Value (US$ Mn) Analysis by Route of Administration, 2017-2032

Figure 134: South Asia & Pacific Anorexiants Market Volume (Tons) Analysis by Route of Administration, 2017-2032

Figure 135: South Asia & Pacific Anorexiants Market Value Share (%) and BPS Analysis by Route of Administration, 2022-2032

Figure 136: South Asia & Pacific Anorexiants Market Y-o-Y Growth (%) Projections by Route of Administration, 2022-2032

Figure 137: South Asia & Pacific Anorexiants Market Value (US$ Mn) Analysis by End User, 2017-2032

Figure 138: South Asia & Pacific Anorexiants Market Volume (Tons) Analysis by End User, 2017-2032

Figure 139: South Asia & Pacific Anorexiants Market Value Share (%) and BPS Analysis by End User, 2022-2032

Figure 140: South Asia & Pacific Anorexiants Market Y-o-Y Growth (%) Projections by End User, 2022-2032

Figure 141: South Asia & Pacific Anorexiants Market Attractiveness by Drug Class, 2022-2032

Figure 142: South Asia & Pacific Anorexiants Market Attractiveness by Route of Administration, 2022-2032

Figure 143: South Asia & Pacific Anorexiants Market Attractiveness by End User, 2022-2032

Figure 144: South Asia & Pacific Anorexiants Market Attractiveness by Country, 2022-2032

Figure 145: MEA Anorexiants Market Value (US$ Mn) by Drug Class, 2022-2032

Figure 146: MEA Anorexiants Market Value (US$ Mn) by Route of Administration, 2022-2032

Figure 147: MEA Anorexiants Market Value (US$ Mn) by End User, 2022-2032

Figure 148: MEA Anorexiants Market Value (US$ Mn) by Country, 2022-2032

Figure 149: MEA Anorexiants Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 150: MEA Anorexiants Market Volume (Tons) Analysis by Country, 2017-2032

Figure 151: MEA Anorexiants Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 152: MEA Anorexiants Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 153: MEA Anorexiants Market Value (US$ Mn) Analysis by Drug Class, 2017-2032

Figure 154: MEA Anorexiants Market Volume (Tons) Analysis by Drug Class, 2017-2032

Figure 155: MEA Anorexiants Market Value Share (%) and BPS Analysis by Drug Class, 2022-2032

Figure 156: MEA Anorexiants Market Y-o-Y Growth (%) Projections by Drug Class, 2022-2032

Figure 157: MEA Anorexiants Market Value (US$ Mn) Analysis by Route of Administration, 2017-2032

Figure 158: MEA Anorexiants Market Volume (Tons) Analysis by Route of Administration, 2017-2032

Figure 159: MEA Anorexiants Market Value Share (%) and BPS Analysis by Route of Administration, 2022-2032

Figure 160: MEA Anorexiants Market Y-o-Y Growth (%) Projections by Route of Administration, 2022-2032

Figure 161: MEA Anorexiants Market Value (US$ Mn) Analysis by End User, 2017-2032

Figure 162: MEA Anorexiants Market Volume (Tons) Analysis by End User, 2017-2032

Figure 163: MEA Anorexiants Market Value Share (%) and BPS Analysis by End User, 2022-2032

Figure 164: MEA Anorexiants Market Y-o-Y Growth (%) Projections by End User, 2022-2032

Figure 165: MEA Anorexiants Market Attractiveness by Drug Class, 2022-2032

Figure 166: MEA Anorexiants Market Attractiveness by Route of Administration, 2022-2032

Figure 167: MEA Anorexiants Market Attractiveness by End User, 2022-2032

Figure 168: MEA Anorexiants Market Attractiveness by Country, 2022-2032

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports

Recommendations

Healthcare

Medically Supervised Weight Loss Services Market

Published : October 2017

Healthcare

Obesity Management Market

Published : June 2021

Healthcare

Bariatric Surgery Devices Market

Published : January 1970

Healthcare

Weight Loss and Obesity Management Market

Published : February 2019

Google translate